Sökning: onr:"swepub:oai:gup.ub.gu.se/283073" >
The natural history...
The natural history of untreated muscle-invasive bladder cancer
-
Martini, A. (författare)
-
Sfakianos, J. P. (författare)
-
- Renstrom-Koskela, L. (författare)
- Karolinska Institutet
-
visa fler...
-
Mortezavi, A. (författare)
-
Falagario, U. G. (författare)
-
- Egevad, L. (författare)
- Karolinska Institutet
-
Hosseini, A. (författare)
-
Mehrazin, R. (författare)
-
Galsky, M. D. (författare)
-
- Steineck, Gunnar, 1952 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences
-
- Wiklund, N. P. (författare)
- Karolinska Institutet
-
visa färre...
-
(creator_code:org_t)
- 2019-08-07
- 2020
- Engelska.
-
Ingår i: Bju International. - : Wiley. - 1464-4096 .- 1464-410X. ; 125:2, s. 270-275
- Relaterad länk:
-
https://gup.ub.gu.se...
-
visa fler...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Objective To describe the natural history of untreated muscle-invasive bladder cancer (MIBC) and compare the oncological outcomes of treated and untreated patients. Patients and Methods We utilised a database encompassing all patients with newly diagnosed bladder cancer in Stockholm, Sweden between 1995 and 1996. The median follow-up for survivors was 14.4 years. Overall, 538 patients were diagnosed with bladder cancer of whom 126 had clinically localised MIBC. Patients were divided into two groups: those who received radical cystectomy or radiation therapy, and those who did not receive any form of treatment. Multivariable Cox or competing-risks regressions were adopted to predict metastasis, overall survival (OS), and cancer-specific mortality (CSM), when appropriate. Analyses were adjusted for age at diagnosis, sex, tumour stage, clinical N stage, and treatment. Results In all, 64 (51%) patients did not receive any definitive local treatment. In the untreated group, the median (interquartile range) age at diagnosis was 79 (63-83) vs 69 (63-74) years in the treated group (P < 0.001). Overall, 109 patients died during follow-up. At 6 months after diagnosis, 38% of the untreated patients had developed metastatic disease and 41% had CSM. The 5-year OS rate for untreated and treated patients was 5% (95% confidence interval [CI] 1, 12%) vs 48% (95% CI 36, 60%), respectively. Patients not receiving any treatment had a 5-year cumulative incidence of CSM of 86% (95% CI 75, 94%) vs 48% (95% CI 36, 60%) for treated patients. Untreated patients had a higher risk of progression to metastatic disease (hazard ratio [HR] 2.40, 95% CI 1.28, 4.51; P = 0.006), death from any cause (HR 2.63, 95% CI 1.65, 4.19; P < 0.001) and CSM (subdistribution HR 2.02, 95% CI 1.24, 3.30; P = 0.004). Conclusions Untreated patients with MIBC are at very high risk of near-term CSM. These findings may help balance the risks vs benefits of integrating curative intent therapy particularly in older patients with MIBC.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- urothelial cancer
- metastasis
- overall survival
- #blcsm
- #BladderCancer
- complications
- cystectomy
- quality
- Urology & Nephrology
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Martini, A.
-
Sfakianos, J. P.
-
Renstrom-Koskela ...
-
Mortezavi, A.
-
Falagario, U. G.
-
Egevad, L.
-
visa fler...
-
Hosseini, A.
-
Mehrazin, R.
-
Galsky, M. D.
-
Steineck, Gunnar ...
-
Wiklund, N. P.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
Bju Internationa ...
- Av lärosätet
-
Göteborgs universitet
-
Karolinska Institutet